Regencell Bioscience Holdings Limited (RGC) Dividend Yield, History & Forecast

Regencell Bioscience Holdings Limited (RGC) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ Capital Market. The most recent ex-dividend date was February 15, 2018, with payment scheduled for February 26, 2018. market capitalization is approximately $15.23B.

Loading quote...

Frequently Asked Questions about Regencell Bioscience Holdings Limited (RGC)

When does Regencell Bioscience Holdings Limited pay its next dividend?
The most recent ex-dividend date was February 15, 2018. The next scheduled dividend payment date is February 26, 2018.
Is Regencell Bioscience Holdings Limited a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Regencell Bioscience Holdings Limited in?
Regencell Bioscience Holdings Limited (RGC) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.